Showing results (41-50 of 102) with videos related to
Sort By:
Pageof 11
Journal of Colloid and Interface Science|February 17, 2024
Improvement of surface stability of Zn anode by a cost-effective ErCl3 additive for realizing high-performance aqueous zinc-ion batteriesYi Xiong, Xingxing Gu, Zixun Liu, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 10, 2024
Incidence, characteristics, and risk factors of hypofibrinogenemia induced by generic tigecycline: a retrospective studyChaoqun Ma, Xiaolei Ren, Ning Pang, et al.Phenomics (Cham, Switzerland)|June 17, 2024
3D Models of Sarcomas: The Next-generation Tool for Personalized MedicineRuiling Xu, Ruiqi Chen, Chao Tu, et al.Frontiers in Genetics|December 20, 2021
Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue SarcomaLin Qi, Ruiling Xu, Lu Wan, et al.Cancers|November 26, 2022
Integrated Analysis of TME and Hypoxia Identifies a Classifier to Predict Prognosis and Therapeutic Biomarkers in Soft Tissue SarcomasRuiling Xu, Lin Qi, Xiaolei Ren, et al.Frontiers in Immunology|July 21, 2022
Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue SarcomaLin Qi, Wenchao Zhang, Xiaolei Ren, et al.Cancer Cell International|April 14, 2020
The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumorsChao Tu, Xiaolei Ren, Jieyu He, et al.Bioengineered|October 30, 2020
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancersChenghao Zhang, Xiaolei Ren, Wenchao Zhang, et al.Cell Death & Disease|June 17, 2020
Oncogene PRR14 promotes breast cancer through activation of PI3K signal pathway and inhibition of CHEK2 pathwayXiaolei Ren, Meijun Long, Zhihong Li, et al.BMC Pharmacology & Toxicology|December 4, 2023
Antibiotics and antibiotic-associated diarrhea: a real-world disproportionality study of the FDA adverse event reporting system from 2004 to 2022Haining Huang, Lanfang Li, Mingli Wu, et al.Pageof 11